Results 21 to 30 of about 27,602 (209)

Equivalence between branded enoxaparin and biosimilar enoxaparin.

, 2023
Equivalence between branded enoxaparin and biosimilar enoxaparin.
Chadli Dziri (14048856), Mehdi Khalfallah (17319734), Wafa Ben Hmida (17319731), Ibtissem Bouasker (17319743), Wejih Dougaz (7506221), Imen Samaali (17319737), Hichem Jerraya (17319740), Ramzi Nouira (17319746)   +7 more
core   +1 more source

Characterizing the delays in adequate thromboprophylaxis after TBI

Trauma Surgery & Acute Care Open, 2021
Background We sought to compare enoxaparin dosing for venous thromboembolism (VTE) prophylaxis in trauma patients with and without traumatic brain injury (TBI) to better understand the time and dose required to reach target anti-Xa levels. Our hypothesis
Eric J Ley, Navpreet K Dhillon, Yassar M Hashim, Naomi Berezin, Felix Yong, Geena Conde, Russell Mason   +6 more
doaj   +1 more source

Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

EClinicalMedicine, 2020
Background: Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection is associated with hypercoagulability caused by direct invasion of endothelial cells and/or proinflammatory cytokine release.
Filippo Albani, Lilia Sepe, Federica Fusina, Chiara Prezioso, Manuela Baronio, Federica Caminiti, Antonella Di Maio, Barbara Faggian, Maria Elena Franceschetti, Marco Massari, Marcello Salvaggio, Giuseppe Natalini   +11 more
doaj   +1 more source

Comparative study: Demographic variables (branded enoxaparin vs biosimilar enoxaparin groups).

, 2023
Comparative study: Demographic variables (branded enoxaparin vs biosimilar enoxaparin groups).
Chadli Dziri (14048856), Mehdi Khalfallah (17319734), Wafa Ben Hmida (17319731), Ibtissem Bouasker (17319743), Wejih Dougaz (7506221), Imen Samaali (17319737), Hichem Jerraya (17319740), Ramzi Nouira (17319746)   +7 more
core   +1 more source

Critically ill patients with edema and ascites may experience subtherapeutic anti-factor Xa levels following abdominal subcutaneous enoxaparin treatment

SAGE Open Medical Case Reports, 2022
Enoxaparin is a low molecular weight heparin that is principally prescribed for the treatment and prevention of thromboembolic disorders. In clinical practice, the abdominal site for subcutaneous enoxaparin administration is most preferable because of ...
Vichapat Tharanon, Theerasuk Kawamatawong   +1 more
doaj   +1 more source

Dosis Efektif Enoxaparin dalam Mencegah Terjadinya Trombosis pada Anastomosis Arteri Femoralis Tikus

JBN (Jurnal Bedah Nasional), 2017
Tujuan: untuk mengetahui dosis efektif enoxaparin dalam mencegah terjadinya trombosis pada anastomosis mikrovaskular. Metode: penelitian ini bersifat eksperimental dengan rancangan the randomized post test only control group design.
I Made Suka Adnyana, Iswinarno Doso Saputro   +1 more
doaj   +1 more source

Comparative study: Post-operative variables (branded enoxaparin vs biosimilar enoxaparin groups).

, 2023
Comparative study: Post-operative variables (branded enoxaparin vs biosimilar enoxaparin groups).
Chadli Dziri (14048856), Mehdi Khalfallah (17319734), Wafa Ben Hmida (17319731), Ibtissem Bouasker (17319743), Wejih Dougaz (7506221), Imen Samaali (17319737), Hichem Jerraya (17319740), Ramzi Nouira (17319746)   +7 more
core   +1 more source

Enoxaparin-induced reactive thrombocytosis: a case report

Thrombosis Journal, 2021
Background Enoxaparin is an anticoagulant that falls in the class of medications called low molecular weight heparins (LMWHs), and is used to prevent or treat patients with deep vein thrombosis (DVT) and pulmonary embolism.
Tao Xiang, Ming Cheng
doaj   +1 more source

Comparative study: Pre and intraoperative variables (branded enoxaparin vs biosimilar enoxaparin groups).

, 2023
Comparative study: Pre and intraoperative variables (branded enoxaparin vs biosimilar enoxaparin groups).
Chadli Dziri (14048856), Mehdi Khalfallah (17319734), Wafa Ben Hmida (17319731), Ibtissem Bouasker (17319743), Wejih Dougaz (7506221), Imen Samaali (17319737), Hichem Jerraya (17319740), Ramzi Nouira (17319746)   +7 more
core   +1 more source

Dose-dependent neuroprotective effect of enoxaparin on cold-induced traumatic brain injury

Neural Regeneration Research, 2017
Recent evidence exists that enoxaparin can reduce brain injury because of its anticoagulant activity. To investigate the potential therapeutic effect of enoxaparin on cold-induced traumatic brain injury, at 20 minutes after modeling, male BALB/c mouse ...
Ilknur Keskin, M Yalcin Gunal, Nilufer Ayturk, Ulkan Kilic, Mehmet Ozansoy, Ertugrul Kilic   +5 more
doaj   +1 more source